Myeloid neoplasms, including acute myeloid leukemia (AML), myeloproliferative neoplasms (MPNs), and myelodysplastic syndromes (MDS), feature clonal dominance and remodeling of the bone marrow niche in a manner that promotes malignant over non-malignant hematopoiesis. This take-over of hematopoiesis by the malignant clone is hypothesized to include hyperactivation of inflammatory signaling and overproduction of inflammatory cytokines. In th
Major progress has been recently made in understanding the molecular pathogenesis of myeloproliferat...
Myeloproliferative neoplasms (MPN) include three main entities: Polycythemia Vera (PV), Essential Th...
Copyright © 2015 Julie Mondet et al. This is an open access article distributed under the Creative C...
Our understanding of inflammation’s role in the pathogenesis of myeloproliferative neoplasm (MPN) is...
Among hematologic malignancies, the classic Philadelphia-negative chronic myeloproliferative neoplas...
Background: Cytokines are key immune mediators in physiological and disease processes, whose increas...
Copyright © 2015 Angela G. Fleischman. This is an open access article distributed under the Creative...
Purpose of reviewChronic inflammation is a characteristic feature of myeloproliferative neoplasm (MP...
Myeloproliferative Neoplasm (MPNs) are a group of chronic blood cancers characterized by the expansi...
Myeloid malignancies occur when a hematopoietic stem cell (HSC) acquires a mutation that provide the...
The term myeloproliferative neoplasms (MPN) refers to a heterogeneous group of diseases including no...
In recent years the evidence is increasing that chronic inflammation may be an important driving for...
International audienceMyeloproliferative neoplasms (MPNs) are a heterogeneous group of clonal diseas...
The chronic Philadelphia-negative myeloproliferative neoplasms (MPNs) are acquired stem cell neoplas...
Myeloproliferative Neoplasms (MPN) are a heterogeneous group of hematological malignancies, consisti...
Major progress has been recently made in understanding the molecular pathogenesis of myeloproliferat...
Myeloproliferative neoplasms (MPN) include three main entities: Polycythemia Vera (PV), Essential Th...
Copyright © 2015 Julie Mondet et al. This is an open access article distributed under the Creative C...
Our understanding of inflammation’s role in the pathogenesis of myeloproliferative neoplasm (MPN) is...
Among hematologic malignancies, the classic Philadelphia-negative chronic myeloproliferative neoplas...
Background: Cytokines are key immune mediators in physiological and disease processes, whose increas...
Copyright © 2015 Angela G. Fleischman. This is an open access article distributed under the Creative...
Purpose of reviewChronic inflammation is a characteristic feature of myeloproliferative neoplasm (MP...
Myeloproliferative Neoplasm (MPNs) are a group of chronic blood cancers characterized by the expansi...
Myeloid malignancies occur when a hematopoietic stem cell (HSC) acquires a mutation that provide the...
The term myeloproliferative neoplasms (MPN) refers to a heterogeneous group of diseases including no...
In recent years the evidence is increasing that chronic inflammation may be an important driving for...
International audienceMyeloproliferative neoplasms (MPNs) are a heterogeneous group of clonal diseas...
The chronic Philadelphia-negative myeloproliferative neoplasms (MPNs) are acquired stem cell neoplas...
Myeloproliferative Neoplasms (MPN) are a heterogeneous group of hematological malignancies, consisti...
Major progress has been recently made in understanding the molecular pathogenesis of myeloproliferat...
Myeloproliferative neoplasms (MPN) include three main entities: Polycythemia Vera (PV), Essential Th...
Copyright © 2015 Julie Mondet et al. This is an open access article distributed under the Creative C...